Safety and pharmacokinetics of a new biosimilar trastuzumab (HL02): a Phase I bioequivalence study in healthy Chinese men
.
Source: Expert Opinion on Biological Therapy - Category: Drugs & Pharmacology Authors: Hong Zhang Ting Liu Min Wu Haijing Wei Cuiyun Li Xiaojiao Li jingrui Liu Hong Chen Yanhua Ding Li Liu Source Type: research